Dec 03, 2021 / 12:30PM GMT
Operator
Good afternoon. This is the chorus call conference operator. Welcome, and thank you for joining the Recordati, the acquirer of Eusa Pharma conference call. (Operator Instructions) At this time, I would like to turn the conference over to Mr. Federica De Medici, Investor Relations and Corporate Communications. Please go ahead, madam.
Federica De Medici - Recordati Industria Chimica e Farmaceutica S.p.A. - Director of IR & Corporate Communications
Thank you, Jodie. Good afternoon or good morning, everyone, and thank you for attending the conference call today. I'm pleased to be here with our new Chairman, Andrea Recordati; our new CEO, Rob Koremans; and Luigi La Corte, our CFO; and Gabriele Finzi, Head of Business Development; and Corrado Castellucci, Head of Recordati Rare Disease.
With a short presentation, we will provide more color on the strategic rationale and present the transaction in more detail. As to slide is available on our website under the Investors section. At the end of the presentation, we will answer any questions you may have. I
Recordati Industria Chimica e Farmaceutica SpA to Discuss About Acquisition of EUSA Pharma (UK) Ltd Call Transcript
Dec 03, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers